tiprankstipranks
Citius Pharmaceuticals (CTXR)
NASDAQ:CTXR

Citius Pharmaceuticals (CTXR) Cash flow

1,233 Followers

Citius Pharmaceuticals Cash Flow

CTXR's free cash flow for Q4 2023 was $-6.14M. For the 2023 fiscal year, CTXR's free cash flow was decreased by $-698.96K and operating cash flow was $-6.14M. See a summary of the company’s cash flow.
Cash Flow
TTM
Sep 23Sep 22Sep 21Sep 20Sep 19
Operating Cash Flow
$ -30.37M$ -29.06M$ -28.36M$ -24.25M$ -16.93M$ -12.44M
Investing Cash Flow
---$ -40.01M$ -1.83K$ 0.00
Financing Cash Flow
$ 13.83M$ 13.83M-$ 134.33M$ 22.90M$ 11.15M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 109.17M$ 26.48M$ 41.71M$ 83.93M$ 13.86M$ 7.89M
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
-----$ 0.00
Issuance Of Capital Stock
$ 13.80M$ 13.80M-$ 18.45M$ 15.58M$ 11.12M
Issuance Of Debt
---$ -172.97K$ 164.58K$ 0.00
Repayment Of Debt
---$ -172.97K$ 0.00-
Free Cash Flow
$ -30.37M$ -29.06M$ -28.36M$ -64.26M$ -16.93M$ -12.44M
Domestic Sales
------
Foreign Sales
------
Currency in USD

Citius Pharmaceuticals Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis